Type: therapy
Status: Research
Developer: Stanford Medicine
Stanford researchers cured Type 1 diabetes in mice without insulin or immune suppression by resetting the immune system to stop attacking beta cells.
Targeted antibody therapy selectively eliminates autoreactive T-cells while preserving protective immunity
Year: 2026